Let’s Continue the Momentum
By Logan Kastner, MRA Director of Marketing and Development | 3 June 2015 In Allies & Partnerships, Prevention
The month of May flew by with a tremendous amount of energy and effort devoted to raising awareness and funds for melanoma. It was inspiring to see so much buzz in the news and on social media about the importance of using sun protection and taking the appropriate steps to...
Leveraged Finance Fights Melanoma Raises $1.6 Million for Melanoma Research
On May 19, the Melanoma Research Alliance (MRA) took over Rockefeller Center for its Fourth Annual Leveraged Finance Fights Melanoma (LFFM) cocktail event. As a customary kick-off to summer, industry executives gathered to raise funds for melanoma research and learn about the importance of early detection and sun safety.
Melanoma Awareness: The Importance of Early Detection
15 May 2015 In Prevention
When caught early, melanoma is highly curable.
Corporate Partners Join in the Fight Against Melanoma
By Logan Kastner, MRA Director of Marketing and Development | 8 May 2015 In Allies & Partnerships
Melanoma Awareness Month is off to a great start! We have so many people and corporations to thank for all they are doing to raise awareness of this deadly cancer. Like so many of you, the Melanoma Research Alliance is committed to ending death and suffering caused by melanoma.
Kicking off Melanoma Awareness Month
Today marks the start of Melanoma Awareness Month, a time of reflection and, indeed, excitement in the field of melanoma research. Eight new drugs have been approved for melanoma in five years, which is remarkable progress. But the death rate for patients with advanced melanoma is still high.
Breakthrough Medicine: Highlights from Milken Institute's Global Conference
Chief Science Officer Louise Perkins moderated a panel at the 2015 Milken Institute Global Conference, titled \"Breakthrough Medicine: Will Finding a Cure Be Just the Start of Saving Lives?\"
A Patient's Take on MRA's Scientific Retreat
Melanoma patient and blogger T.J. Sharpe attended the Melanoma Research Alliance's Scientific Retreat last month. While the retreat is primarily intended as a way for doctors and researchers to share the latest information on melanoma research, we try to include patients, foundations, families and others who care about melanoma.
Dateline Chicago: MRA and GRACE Immunotherapy Forum
By Louise M. Perkins, Ph.D., MRA Chief Science Officer | 28 October 2014 In Events, Science, Treatment
[caption id="attachment_1321" align="alignright" width="273"] Dr. Jedd Wolchok & Rusty Cline, Carlea Bauman & Wendy Selig, Drs. Wolchok, Louise Perkins & Suzanne Topalian, Drs. Michael Atkins, Drew Pardoll & Wolchok[/caption] On Sunday October 26, MRA and its partner GRACE (Global Resource for Advancing Cancer Education) held a forum for patients/caregivers with...
Turning the Tide Against Cancer Through Sustained Medical Innovation
Guest Blog Contributors Edward Abrahams, Ph.D., President, Personalized Medicine Coalition Margaret Foti, Ph.D., M.D. (h.c.), Chief Executive Officer, American Association for Cancer Research Marcia A. Kean, M.B.A., Chairman, Feinstein Kean Healthcare We live in extraordinary times.
Why We Stand Up to Melanoma
[caption id="attachment_1298" align="alignright" width="257"] Wendy Selig with her son Ryan[/caption] It might have been easy to get caught up in the glitz and glamour of a star-studded Hollywood event this past week in LA as Stand Up To Cancer held its latest prime-time broadcast in support of cancer research. After...
Adjuvant Therapy Advocacy ASCO Awareness Biopharma Board Members BRAF Cancer Combination Therapy Detection FDA Francis Collins Grants Health HHS Immunotherapy Louise Perkins Melanoma microbiome MRA News Nonprofits Partners Patient Forum Patient Stories Patient-Centric Care Patients Pediatric Melanoma Prevention Redheads Research Science Social Media Surgeon General Surgeon General's Call to Action to Prevent Skin Cancer Targeted Therapy Teens Treatment Wendy Selig Young Investigators Young People